SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.545+13.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tim Luke who wrote (134)8/16/1997 3:48:00 PM
From: Jeffery E. Forrest   of 3578
 
Geron Corp. Up In Late Trading
On Gene Cloning News

Dow Jones Newswires

NEW YORK -- Shares of Geron Corp. (GERN)
remained active in after-hours trading following the
company's announcement late Thursday that it cloned a
gene related to cancer growth.

PT Discount Brokerage trader Dale Boolton said Geron
shares were trading after hours at 14 1/2, up from their
close of 14.

The company announced that it cloned a gene that makes
a protein that is an essential part of telomerase enzyme,
which allows cancer cells to grow unrestrained.

During the regular session Friday, Geron shares rose 7
1/2, or 115%.

Technology stocks showed slight movement in late trading,
with International Business Machines Corp. (IBM) edging
up to 100 from a close of 99 15/16, and Ascend
Communications Inc. (ASND) trading late at 45 7/16,
unchanged.

- Ted W. Kemp
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext